Cargando…
HOXA1 Is an Antagonist of ERα in Breast Cancer
Breast cancer is a heterogeneous disease and the leading cause of female cancer mortality worldwide. About 70% of breast cancers express ERα. HOX proteins are master regulators of embryo development which have emerged as being important players in oncogenesis. HOXA1 is one of them. Here, we present...
Autores principales: | Belpaire, Magali, Ewbank, Bruno, Taminiau, Arnaud, Bridoux, Laure, Deneyer, Noémie, Marchese, Damien, Lima-Mendez, Gipsi, Baurain, Jean-François, Geerts, Dirk, Rezsohazy, René |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417444/ https://www.ncbi.nlm.nih.gov/pubmed/34490074 http://dx.doi.org/10.3389/fonc.2021.609521 |
Ejemplares similares
-
Molecular Analysis of the HOXA2-Dependent Degradation of RCHY1
por: Bridoux, Laure, et al.
Publicado: (2015) -
HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner
por: Taminiau, Arnaud, et al.
Publicado: (2016) -
The Pbx Interaction Motif of Hoxa1 Is Essential for Its Oncogenic Activity
por: Delval, Stéphanie, et al.
Publicado: (2011) -
The Homeodomain Transcription Factor Hoxa2 Interacts with and Promotes the Proteasomal Degradation of the E3 Ubiquitin Protein Ligase RCHY1
por: Bergiers, Isabelle, et al.
Publicado: (2013) -
HOX Protein Activity Regulation by Cellular Localization
por: Bridoux, Laure, et al.
Publicado: (2021)